Alfenta side effects by duration, gender and age - a phase IV clinical study of FDA data
Summary:
Side effects are reported by people who take Alfenta. Common side effects include abdominal pain among females, and toxic epidermal necrolysis among males.
The phase IV clinical study is created by eHealthMe based on 1,425 reports from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
1,425 people who take Alfenta and have side effects are studied.
What is Alfenta?
Alfenta has active ingredients of alfentanil hydrochloride. Currently, eHealthMe is studying from 1,430 Alfenta users.
Number of Alfenta reports submitted per year:
Alfenta side effects by time on the drug *:
Alfenta side effects by gender *:
Alfenta side effects by age *:
* Approximation only. Some reports may have incomplete information.
Do you take Alfenta?
Personalize this study to your gender and ageHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How the study uses the data?
The study is based on alfentanil hydrochloride (the active ingredients of Alfenta) and Alfenta (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered.
Related studies
Alternative drugs to, pros and cons of Alfenta:
- Alfenta (1,430 reports)
Common Alfenta side effects:
- Erythema multiforme (a type of hypersensitivity reaction): 111 reports
- Anaphylaxis (serious allergic reaction that is rapid in onset and may cause death): 110 reports
All Alfenta side effects from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zWho is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Omniscan and Pinguecula - 4 seconds ago
- Vecuronium Bromide and Myopathy - 17 seconds ago
- Omeprazole and Culture Stool Positive - 19 seconds ago
- Byetta and Tachycardia Aggravated - 23 seconds ago
- Flonase and Lyme Disease - a minute ago
- Oxycontin and Tadalafil drug interaction - a minute ago
- Magnesium Citrate and Oxybutynin drug interaction - a minute ago
- Lisinopril and Osteosclerosis - a minute ago
- Dimeticone and Arrhythmias - 2 minutes ago
- Levothroid and Gout Aggravated - 2 minutes ago